decoration decoration
Stories

GROKLAW
When you want to know more...
decoration
For layout only
Home
Archives
Site Map
Search
About Groklaw
Awards
Legal Research
Timelines
ApplevSamsung
ApplevSamsung p.2
ArchiveExplorer
Autozone
Bilski
Cases
Cast: Lawyers
Comes v. MS
Contracts/Documents
Courts
DRM
Gordon v MS
GPL
Grokdoc
HTML How To
IPI v RH
IV v. Google
Legal Docs
Lodsys
MS Litigations
MSvB&N
News Picks
Novell v. MS
Novell-MS Deal
ODF/OOXML
OOXML Appeals
OraclevGoogle
Patents
ProjectMonterey
Psystar
Quote Database
Red Hat v SCO
Salus Book
SCEA v Hotz
SCO Appeals
SCO Bankruptcy
SCO Financials
SCO Overview
SCO v IBM
SCO v Novell
SCO:Soup2Nuts
SCOsource
Sean Daly
Software Patents
Switch to Linux
Transcripts
Unix Books
Your contributions keep Groklaw going.
To donate to Groklaw 2.0:

Groklaw Gear

Click here to send an email to the editor of this weblog.


To read comments to this article, go here
Another Patent Bites the Dust Thanks to PubPat
Wednesday, December 01 2004 @ 05:33 PM EST

Here is the press release that PubPat has won another victory.

**********************************
PUBPAT SCORES ANOTHER VICTORY: Columbia University Abandons Assertion of Challenged Cotransformation Patent<P>

NEW YORK -- The Public Patent Foundation ("PUBPAT") announced today that Columbia University has voluntarily abandoned assertion of its most recently acquired patent on cotransformation, a process that is the basis for a wide range of pharmaceutical products, including Epogen® for anemia, Activase® for heart attacks and stroke, Avonex® for multiple sclerosis, and Recombinate® for hemophilia. PUBPAT challenged the patent in February by filing a request for reexamination with the United States Patent and Trademark Office, which granted the request in May.

The patent was not only the subject of PUBPAT's reexamination request, but was also involved in several lawsuits throughout the country. In those cases, although not expressly conceding that the patent was invalid, Columbia University recently waived any right to assert the patent or any similar patent at any time.

"Patents like this that undeservingly restrict the public's right to use critical technology are issued far too routinely, giving private parties unearned control over important scientific advances and crippling those who would otherwise benefit from using such technology," said Dan Ravicher, PUBPAT's Executive Director. "Getting Columbia University to abandon assertion of the patent is a total victory for PUBPAT and for the public that has been harmed by the unjust issuance of this patent."

Cotransformation is a widely used biotechnology process for inserting foreign DNA into a host cell to produce certain proteins. More information about the challenged cotransformation patent, including a copy of PUBPAT's Request for Reexamination, the Patent Office's Order Granting the request, and Columbia University's Covenant Not to Sue, can be found at http://www.pubpat.org/Protecting.htm.

Contact:

Karen Duffin, Bite Communications: (415) 365-0459; Karen.Duffin@bitepr.com.

About PUBPAT:

The Public Patent Foundation ("PUBPAT") is a not-for-profit public service organization working to protect the public from the harms caused by wrongly issued patents and unsound patent policy. To be kept informed of PUBPAT News, subscribe to the PUBPAT News List by sending an email with "subscribe" in the subject line to news-request@pubpat.org. To be removed from the PUBPAT News List, send an email with "unsubscribe" in the subject line to news-request@pubpat.org.

  View Printable Version


Groklaw © Copyright 2003-2013 Pamela Jones.
All trademarks and copyrights on this page are owned by their respective owners.
Comments are owned by the individual posters.

PJ's articles are licensed under a Creative Commons License. ( Details )